MedTrace Logo

Amphetamine Induced Adult Respiratory Distress Syndrome

NCT05611385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2022-11-10

No results posted yet for this study

Summary

Methamphetamine and amphetamine has various cardiovascular and central nervous system effects. Long-term use is associated with many adverse health effects including cardiomyopathy, hemorrhagic, and ischemic stroke. Death is usually caused by cardiovascular collapse and while amphetamine abuse has been considered as a potential cause of acute respiratory distress syndrome, the reports are usually anecdotal. This investigation considers reviewing individuals with few to zero medical conditions who develop acute respiratory distress syndrome and are methamphetamine positive

Conditions

  • Burns
  • Acute Lung Injury
  • Acute Respiratory Distress Syndrome
  • Methamphetamine Abuse

Interventions

OTHER

Difference in development of Acute Lung Injury in Amphetamine positive and negative patients

No Intervention

Sponsors & Collaborators

  • Arrowhead Regional Medical Center

    lead OTHER

Principal Investigators

  • Aldin Malkoc, MD · Arrowhead Regional Medical Center

  • David T Wong, MD · Arrowhead Regional Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-01-01
Completion
2020-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611385 on ClinicalTrials.gov